Acute lung dysfunction of noninfectious etiology, known as idiopathic pneumonia syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation (HSCT). IT ws first thught to be autoimmune and ti responded to sterodis, buyt a study of Enbrel did not show an advantage to using Enbrel. Nore recent thinking sabout it suggests that some cases may involve an acute infection. Enbrel remains experiementall and needs much more study before routine use.
CLINICAL / MEDICAL REFERENCES
Yanik GA et al, Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. Biol Blood Marrow Transplant. 2014 Jun;20(6):858-64..